CCL2 and diabetic kidney disease: MCP-1, also referred to as CC chemokine ligand 2, has been confirmed to elevate in kidney biopsies from patients with DKD, which may elicit inflammatory cell recruitment, migration, and the interaction of inflammatory cells, finally contributing to kidney injury [59,60].